Compare Novavax Inc (NVAX) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs iShares 10 20 Year Treasury Bond ETF — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while iShares 10 20 Year Treasury Bond ETF trades at $97.83. The key difference: Novavax Inc is trading nearer its 52-week high, iShares 10 20 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| NVAX | TLH | |
|---|---|---|
Market Cap | $1.30B | — |
Sector | Health | Fixed Income |
52-Week High | $11.19 | $105.36 |
52-Week Low | $6.22 | $97.13 |
Enterprise Value | $800.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
